A detailed history of Raiffeisen Bank International Ag transactions in Moderna, Inc. stock. As of the latest transaction made, Raiffeisen Bank International Ag holds 4,018 shares of MRNA stock, worth $144,246. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,018
Holding current value
$144,246
% of portfolio
0.0%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025

BUY
$36.85 - $63.93 $148,063 - $256,870
4,018 New
4,018 $159 Million

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $14B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Raiffeisen Bank International Ag Portfolio

Follow Raiffeisen Bank International Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Raiffeisen Bank International Ag, based on Form 13F filings with the SEC.

News

Stay updated on Raiffeisen Bank International Ag with notifications on news.